Colinz Laboratories Ltd.

View in App
41.15 ▼0%

25 April 2024, 04:01:00 PM

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.findoc-cll.in
Market Cap 10.37 Cr.
Enterprise Value(EV) 4.48 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.89 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 21.82 Trailing Twelve Months Ending 2023-12
Industry PE 41.74 Trailing Twelve Months Ending 2023-12
Book Value / Share 34.29 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.20 Calculated using Price: 41.15
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.25 Cr. 2,519,100 Shares
FaceValue 10
About Colinz Laboratories Ltd.
Pharmaceutical Formulations (of all dosages forms) TabletsCapsulesParenteralsCreams/ Ointments/LotionsDry PowderLiquid OralsSoft Gelatine Capsules

Colinz Laboratories Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Colinz Laboratories Ltd. Performance

View details >>
1 Day
1 Week
+3.52%
1 Month
+6.03%
3 Month
+4.97%
6 Month
+2.36%
1 Year
+7.72%
2 Year
+46.96%
5 Year
+564.78%
10 Year
+960.57%

Colinz Laboratories Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 1.55 1.52 2.21 3.48 1.79 1.91 2.94 4.53 5.78
Return on Capital Employed (%) 3.12 3.27 3.12 3.25 3.45 3.3 4.28 6.76 7.86
Return on Assets (%) 0.94 0.93 1.45 2.39 1.3 1.45 2.2 3.39 4.54

Colinz Laboratories Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 6 6 7 7 7 7 7 8 8 9
Non Curr. Liab. 3 2 1 1 1 0 0 0 0 0
Curr. Liab. 2 1 2 2 2 2 3 2 2 2
Minority Int.
Equity & Liab. 11 10 10 10 9 9 10 10 10 11
Non Curr. Assets 5 4 4 4 4 3 3 3 2 3
Curr. Assets 6 5 5 6 6 6 7 7 8 8
Misc. Exp. not W/O
Total Assets 11 10 10 10 9 9 10 10 10 11

Colinz Laboratories Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 8 8 8 8 8 8 6 7 7 7
Other Income 0 0 0 0 0 0 0 0 0 0
Total Income 8 8 8 8 8 8 6 7 7 7
Total Expenditure -7 -8 -8 -8 -7 -7 -6 -6 -7 -7
PBIDT 1 1 1 0 0 0 1 1 1 1
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 0 0 0 0
Exceptional Items
PAT 0 0 0 0 0 0 0 0 0 0
Adjusted EPS 0 0 0 1 0 0 1 1 2 2

Colinz Laboratories Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 1 0 1 0 0 0 1 2 0 0
Cash Fr. Inv. 0 0 0 0 0 0 0 0
Cash Fr. Finan. 0 0 -1 0 0 0 0 0 0 0
Net Change 0 1 0 0 0 0 1 2 1 1
Cash & Cash Eqvt 1 2 2 2 2 2 3 5 5 6

Colinz Laboratories Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 36.38 66.01 65.93 66.00 66.00 66.00 66.00 66.00 66.00
Public 63.62 33.99 34.07 34.00 34.00 34.00 34.00 34.00 34.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Colinz Laboratories Ltd. Announcements

View details >>
Mon, 15 Apr 2024
Compliance Certificate Under Regulation 7(3) Of SEBI(LODR) Regulation 2015 For The Year Ended 31-03-2024
Please find the attached The certificate under Regulation 7(3) of SEBI(LODR) Regulation 2015 for the year ended 31-03-2024.Kindly take the same on records For Colinz Labs LtdDr. Mani L S.Compliance Officer
Wed, 10 Apr 2024
Compliance Under Regulation 40(9) As On 31-03-24
Submission of certificate from practicing Company Secretary under Regulation 40(9) for the quarter ended as on 31-03-2024.
Wed, 10 Apr 2024
Non-Applicability Of Annual Secretarial Compliances Report Under Regulation 24A Of SEBI(LODR) Regulations 2015 As On 31-03-2024
Please find the attached declaration under Regulation 24(A) of SEBI(LODR) Regulations 2015 as on 31-03-2024 (Non Applicability of Annual Secretarial Compliances Report )Kindly take the same on records.

Colinz Laboratories Ltd. Technical Scans

View details >>
Thu, 25 Apr 2024
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Colinz Laboratories Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 364,830.88 1,520.15 0%
Cipla Ltd. 113,471.29 1,406.20 0%
Dr. Reddy's Laboratories Ltd. 103,713.42 6,218.75 0%
Divi's Laboratories Ltd. 101,959.84 3,843.80 0%
Zydus Lifesciences Ltd. 95,944.41 951.25 0%
Mankind Pharma Ltd. 95,926.91 2,398.55 0%
Apollo Hospitals Enterprise Ltd. 91,425.47 6,384.10 0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.96 1,520.15 0%
Cipla Ltd. Consolidated 2023-12 30.60 1,406.20 0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.84 6,218.75 0%
Divi's Laboratories Ltd. Consolidated 2023-12 73.73 3,843.80 0%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.26 951.25 0%
Mankind Pharma Ltd. Consolidated 2023-12 55.54 2,398.55 0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 115.83 6,384.10 0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,520.15 0%
Cipla Ltd. Consolidated 2023-12 4.38 1,406.20 0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.86 6,218.75 0%
Divi's Laboratories Ltd. Consolidated 2023-12 7.82 3,843.80 0%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.09 951.25 0%
Mankind Pharma Ltd. Consolidated 2023-12 10.80 2,398.55 0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.54 6,384.10 0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,520.15 0%
Cipla Ltd. Consolidated 2023-03 0.02 1,406.20 0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,218.75 0%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,843.80 0%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 951.25 0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,398.55 0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,384.10 0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 0%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,520.15 0%
Cipla Ltd. Consolidated 2023-03 12.85 1,406.20 0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,218.75 0%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,843.80 0%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 951.25 0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,398.55 0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,384.10 0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,520.15 0%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,406.20 0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,218.75 0%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,843.80 0%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 951.25 0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,398.55 0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,384.10 0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,520.15 0%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,406.20 0%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,218.75 0%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,843.80 0%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 951.25 0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,398.55 0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,384.10 0%

Colinz Laboratories Ltd. FAQ's

What is Colinz Laboratories share price?
Can I buy Colinz Laboratories shares now?
What is the Market Cap of Colinz Laboratories?
What are the key metrics to analyse Colinz Laboratories?
What is the 52 Week High and Low of Colinz Laboratories?